Since endothelial lipase is a major determinant of serum HDL-C level, the study of its physiological role is of particular interest for the development of anti-atherogenic therapies (low level of HDL-C is a recognized risk factor for cardiovascular disease) [62,63]. This evidence concerns the gene LIPG and cardiovascular disorder.